MarketCapTrends
ANIX
Anixa Biosciences Inc. (ANIX)
NASDAQ · Healthcare

Anixa Biosciences Inc. Shareholder Equity 2010–2024

Anixa Biosciences Inc. annual/quarterly shareholder equity history from 2010 to 2024. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.

  • Anixa Biosciences Inc. shareholder equity for the quarter ending October 31, 2024 were 20.0M, a 17.83% decrease year-over-year.
  • Anixa Biosciences Inc. shareholder equity for 2024 were 20.0M, a 17.83% decrease from 2023.
  • Anixa Biosciences Inc. shareholder equity for 2023 were 24.3M, a 31.33% decrease from 2021.
  • Anixa Biosciences Inc. shareholder equity for 2021 were 35.4M, a 576.90% increase from 2019.
  • Anixa Biosciences Inc. shareholder equity for 2019 were 5.2M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Anixa Biosciences Inc. Annual Shareholder Equity (Millions of US $)
2024$20
2023$24
2021$35
2019$5
2018$5
2017$8
2016$1
2015$5
2014$4
2013$-3
2012$-1
2011$1
2010$5
Anixa Biosciences Inc. Quarterly Shareholder Equity (Millions of US $)
2024-10-31$20
2023-10-31$24
2021-10-31$35
2019-10-31$5
2018-10-31$5
2017-10-31$8
2016-10-31$1
2015-10-31$5
2014-10-31$4
2013-10-31$-3
2012-10-31$-1
2011-10-31$1
2010-10-31$5

Anixa Biosciences Inc. Shareholder Equity — FAQ

Anixa Biosciences Inc. (ANIX) shareholder equity over the last 13 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see ANIX's shareholder equity history?

The chart and table above show Anixa Biosciences Inc.'s shareholder equity by year and by quarter, including the growth rate.